slow responder to glp 1 Replying @drizzydreww24 time frame | what is a gp New *promising* study for GLP1

Eli Lilly's advertisements, which Novo Nordisk claims are misleading, were reportedly based on a head-to-head study comparing Zepbound against Wegovy

From a neuroscientist to fitness enthusiast At 38, Kellys life is a whirlwind of activity

Known countermeasures to weight loss-associated bone loss include dietary factors, ensuring adequate protein, calcium, and vitamin D, along with participating in progressive resistance training (RT) to support skeletal muscle health and maintain long-term weight loss ( Statements Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation

2024 Feb 8;18:373-382

Evidence and Licensing Limits GLP-1 medicines are licensed for adults living with overweight or obesity